[EN] C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY<br/>[FR] TRITERPÉNOÏDES MODIFIÉS EN C-17 ET C-3 PRÉSENTANT UNE ACTIVITÉ INHIBITRICE DE LA MATURATION DU VIH
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012106190A1
公开(公告)日:2012-08-09
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, C-17 and C-3 modified triterpenoids that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formulas I, II and III. These compounds are useful for the treatment of HIV and AIDS.
具有药物和生物影响特性的化合物,其药物组合物和使用方法已列出。具体来说,提供了具有独特抗病毒活性的C-17和C-3修饰三萜类化合物,作为HIV成熟抑制剂,如公式I、II和III所代表的化合物。这些化合物对治疗HIV和艾滋病有用。